Australian (ASX) Stock Market Forum

Reply to thread

'Market Matters' Friday afternoon report

Not Held

  • ResMed (RMD) +5.92% reported after hours in the US with revenue of $1.22bn up 11% YoY and ahead of $1.19bn expected,  EPS of $2.20 vs $2.07 consensus. Commentary was strong, the CEO Mick Farrell saying “Our first-quarter fiscal year 2025 results reflect ongoing momentum and strong execution across all areas of our business.”


Top